$3.27 Billion is the total value of Camber Capital Management LP's 45 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 41.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SRPT | Sell | SAREPTA THERAPEUTICS INC | $165,810,000 | +19.6% | 1,500,000 | -18.9% | 5.08% | -15.6% |
| PRGO | Sell | PERRIGO CO PLC | $89,150,000 | -20.1% | 2,500,000 | -9.1% | 2.73% | -43.6% |
| IONS | Sell | IONIS PHARMACEUTICALS INC | $85,143,000 | -14.8% | 1,925,000 | -28.7% | 2.61% | -39.9% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $67,816,000 | -45.4% | 800,000 | -46.7% | 2.08% | -61.5% |
| INCY | Sell | INCYTE CORP | $49,980,000 | -45.2% | 750,000 | -37.5% | 1.53% | -61.3% |
| EXEL | Sell | EXELIXIS INC | $21,168,000 | -38.4% | 1,350,000 | -18.2% | 0.65% | -56.5% |
| RETA | Sell | REATA PHARMACEUTICALS INCcl a | $12,565,000 | -72.4% | 500,000 | -66.7% | 0.38% | -80.5% |
| Exit | 2SEVENTY BIO INC | $0 | – | -48,600 | -100.0% | -0.03% | – | |
| SDC | Exit | SMILEDIRECTCLUB INC | $0 | – | -1,000,000 | -100.0% | -0.04% | – |
| PACB | Exit | PACIFIC BIOSCIENCES CALIF IN | $0 | – | -424,600 | -100.0% | -0.08% | – |
| EXAS | Exit | EXACT SCIENCES CORP | $0 | – | -300,000 | -100.0% | -0.51% | – |
| EVH | Exit | EVOLENT HEALTH INCcl a | $0 | – | -1,000,000 | -100.0% | -1.33% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TEVA PHARMACEUTICALS INDS LTD | 34 | Q3 2023 | 9.7% |
| BROOKDALE SR LIVING INC | 32 | Q3 2023 | 5.0% |
| PERRIGO CO PLC | 29 | Q3 2023 | 7.1% |
| TENET HEALTHCARE CORP | 28 | Q3 2023 | 8.5% |
| NEKTAR THERAPEUTICS | 28 | Q1 2022 | 9.8% |
| UNIVERSAL HLTH SVCS INC | 25 | Q3 2023 | 9.9% |
| MYRIAD GENETICS INC | 24 | Q3 2023 | 5.0% |
| SAREPTA THERAPEUTICS INC | 23 | Q3 2023 | 6.0% |
| MYLAN NV | 21 | Q3 2020 | 10.1% |
| AMAG PHARMACEUTICALS INC | 21 | Q3 2020 | 4.0% |
View Camber Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC | February 02, 2023 | ? | ? |
| Solid Biosciences Inc. | December 12, 2022 | ? | ? |
| AVROBIO, Inc. | February 14, 2022 | ? | ? |
| COLLEGIUM PHARMACEUTICAL, INC | February 14, 2022 | ? | ? |
| AMAG PHARMACEUTICALS, INC. | February 16, 2021 | ? | ? |
| Atara Biotherapeutics, Inc. | February 16, 2021 | ? | ? |
| Change Healthcare Inc. | February 16, 2021 | ? | ? |
| GLYCOMIMETICS INC | February 16, 2021 | ? | ? |
| Clovis Oncology, Inc. | February 14, 2020 | ? | ? |
| Cyclerion Therapeutics, Inc. | February 14, 2020 | ? | ? |
View Camber Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| SC 13G | 2023-10-30 |
| 13F-HR | 2023-08-14 |
View Camber Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.